Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    NCT01233505
Previous Study | Return to List | Next Study

Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors

This study has been terminated.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: November 2, 2010
Last updated: April 1, 2014
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)